Denali Therapeutics Inc. (DNLI) — 8-K Filings

8-K Filings (18)

• 8-K Filing — Mar 31, 2026
• Denali Therapeutics Files 8-K for Regulation FD Disclosure — Mar 25, 2026
  Denali Therapeutics Inc. filed an 8-K on March 25, 2026, under Item 7.01, Regulation FD Disclosure, indicating a significant announcement or event that the comp
• Denali Therapeutics Enters Material Definitive Agreement — Dec 10, 2025 Risk: medium
  Denali Therapeutics Inc. announced on December 9, 2025, that it has entered into a material definitive agreement. The company, incorporated in Delaware with its
• 8-K Filing — Dec 4, 2025
• Denali Therapeutics Files 8-K — Oct 14, 2025 Risk: low
  Denali Therapeutics Inc. filed an 8-K on October 14, 2025, reporting events on October 13, 2025. The filing indicates a Regulation FD Disclosure and includes Fi
• Denali Therapeutics Files 8-K — Jul 7, 2025 Risk: low
  Denali Therapeutics Inc. filed an 8-K on July 7, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain s
• Denali Therapeutics Files 8-K — Jun 3, 2025 Risk: low
  Denali Therapeutics Inc. filed an 8-K on June 3, 2025, reporting on a material definitive agreement, submission of matters to a vote of security holders, and fi
• Denali Therapeutics Files 8-K on Financials — May 6, 2025 Risk: low
  Denali Therapeutics Inc. filed an 8-K on May 6, 2025, reporting on its results of operations and financial condition. The filing includes financial statements a
• Denali Therapeutics Files 8-K — Apr 2, 2025 Risk: low
  On April 2, 2025, Denali Therapeutics Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements and exhibits. N
• Denali Therapeutics Files 8-K for Regulation FD Disclosure — Mar 5, 2025 Risk: low
  Denali Therapeutics Inc. filed an 8-K on March 5, 2025, reporting a Regulation FD Disclosure. The filing does not contain specific financial figures or material
• Denali Therapeutics Files 8-K — Jan 13, 2025 Risk: low
  Denali Therapeutics Inc. filed an 8-K on January 13, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not conta
• Denali Therapeutics Files 8-K — Jan 7, 2025 Risk: low
  Denali Therapeutics Inc. filed an 8-K on January 7, 2025, reporting an event on January 6, 2025. The filing is related to Regulation FD Disclosure and Financial
• Denali Therapeutics Changes Fiscal Year End — Nov 18, 2024 Risk: low
  Denali Therapeutics Inc. filed an 8-K on November 18, 2024, reporting a change in its fiscal year end to December 31st. This change was effective as of November
• Denali Therapeutics Files 8-K for Regulation FD Disclosure — Oct 10, 2024 Risk: medium
  On October 10, 2024, Denali Therapeutics Inc. filed an 8-K to disclose a material event. The filing indicates a Regulation FD Disclosure, suggesting important i
• Denali Therapeutics Files 8-K for Shareholder Votes & Financials — May 31, 2024 Risk: low
  Denali Therapeutics Inc. filed an 8-K on May 31, 2024, to report on matters submitted to a vote of security holders and to file financial statements and exhibit
• Denali Reports Material Agreement & Unregistered Equity Sales — Feb 27, 2024 Risk: medium
  Denali Therapeutics Inc. filed an 8-K on February 27, 2024, reporting the entry into a material definitive agreement and unregistered sales of equity securities
• Denali Therapeutics Files 8-K on Regulation FD Disclosure — Feb 16, 2024 Risk: low
  Denali Therapeutics Inc. filed an 8-K on February 16, 2024, under Regulation FD Disclosure. The filing indicates an event reported on February 16, 2024, and was
• Denali Therapeutics Files 8-K for Regulation FD Disclosure — Jan 8, 2024
  Denali Therapeutics Inc. filed an 8-K on January 8, 2024, under Regulation FD Disclosure and Financial Statements and Exhibits. This filing indicates that Denal

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX